230+ SPEAKERS, INCLUDING:

 

 

ALL 2020 SPEAKERS

 

Stewart Abbot, Chief Scientific Officer, Adicet Bio

Stewart Abbot | Chief Scientific Officer | Adicet Bio » speaking at Advanced Therapies

Elsa Abranches, Group Leader, Section Of Stem Cell Biology, NIBSC/MHRA

Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center

Nada Alaaeddine, Head Of The Regenerative And Inflammation Lab In The Faculty Of Medicine, Lebanese University

Nada Alaaeddine | Head Of The Regenerative And Inflammation Lab In The Faculty Of Medicine | Lebanese University » speaking at Advanced Therapies

Marco Alessandrini, Managing Director, Antion Biosciences

Marco Alessandrini | Managing Director | Antion Biosciences » speaking at Advanced Therapies

Eric Alton, Professor Of Gene Therapy And Respiratory Medicine, Faculty of Medicine National Heart and Lung Institute Imperial College London

Aglaia Athanassiadou, Professor Emeritus, University of Patras

Mimoun Azzouz, Neuroscience Professor, University of Sheffield

Mimoun Azzouz | Neuroscience Professor | University of Sheffield » speaking at Advanced Therapies

Stefano Baila, director of operations, Anemocyte

Frank Barry, Scientific Director, Regenerative Medicine Institute

Frank Barry | Scientific Director | Regenerative Medicine Institute » speaking at Advanced Therapies

Nina Bauer, Chief Commercial Officer, FloDesign Sonics

Nina Bauer | Chief Commercial Officer | FloDesign Sonics » speaking at Advanced Therapies

Ardeshir Bayat, Senior Associate Professor, The University of Manchester

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Mark Beards, Non Executive Director, Sutura Therapeutics

Francesca Bellintani, Downstream Process Development Manager, Molmed SpA

David Blakey, Chief Scientific Officer, MiNA Therapeutics

Axel Boehnke, Director Market Access Eu North, PTC Therapeutics

Luc Boileau, Chairman And Chief Executive Officer, INESSS

Luc Boileau | Chairman And Chief Executive Officer | INESSS » speaking at Advanced Therapies

Jeanne Bolger, Vice President of Venture Investments, Johnson & Johnson

Jeanne Bolger | Vice President of Venture Investments | Johnson & Johnson » speaking at Advanced Therapies

Claire Booth, Associate Professor In Gene Therapy, UCL Great Ormond Street Institute of Child Health

Claire Booth | Associate Professor In Gene Therapy | UCL Great Ormond Street Institute of Child Health » speaking at Advanced Therapies

Luis Borges, Chief Scientific Officer, Century Therapeutics

Amandine Breton, Cell Therapy Operations Manager, Orchard Therapeutics

Tara Britt, Associate Chairman, NC Rare Disease Innovations Institute

Tara Britt | Associate Chairman | NC Rare Disease Innovations Institute » speaking at Advanced Therapies

Philip John Brooks, Program Director, National Center for Advancing Translational Sciences

Gabriel Brooks, Vice President, Translational And Clinical Research And Development, 4DMT

Didier Caizergues, Director Of Regulatory Affairs, Genethon

Bradley Campbell, Chief Business Officer, Amicus Therapeutics Inc

Iain Campbell, Director Of Nursing And Co-Founder, Wren Healthcare

Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica

Paul S Carter, Director, Head Vector Processing, Quell Therapeutics

Paul S Carter | Director, Head Vector Processing | Quell Therapeutics » speaking at Advanced Therapies

Paul Cashen, Bioprocess Specialist, Pall

Paul Cashen | Bioprocess Specialist | Pall » speaking at Advanced Therapies

Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics

Frederic Chereau | Chief Executive Officer | LogicBio Therapeutics » speaking at Advanced Therapies

Katherine Cohen, Venture Partner, Panacea Venture

Katherine Cohen | Venture Partner | Panacea Venture » speaking at Advanced Therapies

Pierre-Albert Colcomb, Business Development Manager, Genethon

Pierre-Albert Colcomb | Business Development Manager | Genethon » speaking at Advanced Therapies

Aurore Colella, Marketing, Terrapinn Holdings

Aurore Colella | Marketing | Terrapinn Holdings » speaking at Advanced Therapies

Vittorio Colizzi, Professor Of Immunology, University of Rome Tor Vergata

Vittorio Colizzi | Professor Of Immunology | University of Rome Tor Vergata » speaking at Advanced Therapies

Stuart Collinson, Chairman And Chief Executive Officer, Oxstem

Stuart Collinson | Chairman And Chief Executive Officer | Oxstem » speaking at Advanced Therapies

Angela Columbano, Head Of Business Development And Partnership, Genethon

Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics

Elena Costariol, Engd Researcher, UCL

Christina Coughlin, Chief Medical Officer, Rubius Therapeutics

Conrad Russell Y Cruz, Assistant Professor, Children's National Medical Center; Co-Founder, Children's National Medical Center

Armando Cuesta Díaz, Partner, Ilana Capital

Davide Danovi, Director, Hipsci Cell Phenotyping Programme, King's College London

Eric Michael David, Chief Executive Officer, BridgeBio-Gene Therapy

Gregory Davis, Vice President, Genome Engineering, Sangamo Therapeutics

Francesco Dazzi, Professor Of Regenerative And Hematological Medicine, King's College London

Francesco Dazzi | Professor Of Regenerative And Hematological Medicine | King's College London » speaking at Advanced Therapies

Michele de Guise, Scientific Vice-President, INESSS

Michele de Guise | Scientific Vice-President | INESSS » speaking at Advanced Therapies

Riette De Jager, Marketing Manager, Terrapinn

Riette De Jager | Marketing Manager | Terrapinn » speaking at Advanced Therapies

Joery De Kock, Professor, Vrije Universiteit Brussel

Joery De Kock | Professor | Vrije Universiteit Brussel » speaking at Advanced Therapies

Johannes De Munter, Chief Executive Officer, Neuroplast

Graciana Diez-Roux, Chief Scientific Officer, Telethon Institute of Genetics and Medicine

Graciana Diez-Roux | Chief Scientific Officer | Telethon Institute of Genetics and Medicine » speaking at Advanced Therapies

Tanner Dockendorf, Client Relations Manager, Aldevron

Tanner Dockendorf | Client Relations Manager | Aldevron » speaking at Advanced Therapies

Joe Dupere, Chief Executive Officer, Rexgenero Ltd..

Dominik Egger, Research Associate, University Of Natural Resources And Life Sciences Vienna

Magdi Elsallab, Phd Student, Charite

Magdi Elsallab | Phd Student | Charite » speaking at Advanced Therapies

Kris Elverum, Senior Vice President Of Business Development And Strategy, Rubius Therapeutics

Kris Elverum | Senior Vice President Of Business Development And Strategy | Rubius Therapeutics » speaking at Advanced Therapies

Victoria English, Victoria English, Co-Founder And Editor, Evernow Publications

Antoine Espinet, Chief Executive Officer, MicrofluidX

Debora Esposito, Assistant Professor, N.C. State University

Debora Esposito | Assistant Professor | N.C. State University » speaking at Advanced Therapies

Marco Fadda, ATMP Solutions Manager, COMECER GROUP

Marco Fadda | ATMP Solutions Manager | COMECER GROUP » speaking at Advanced Therapies

Dr Suzanne Farid, Biochemical Engineering Professor, University College London

Dr Suzanne Farid | Biochemical Engineering Professor | University College London » speaking at Advanced Therapies

Prof Farzin Farzaneh, Professor Of Molecular Medicine, King's College Hospital

Marcie Finney, Associate Director, Cleveland Cord Blood Center

Marcie Finney | Associate Director | Cleveland Cord Blood Center » speaking at Advanced Therapies

Miguel Forte, Chief Executive Officer, Bone Therapeutics

Miguel Forte | Chief Executive Officer | Bone Therapeutics » speaking at Advanced Therapies

Mike Fraser, Head of EMEA Region, AveXis

Mike Fraser | Head of EMEA Region | AveXis » speaking at Advanced Therapies

Thomas Mørch Frøsig, Chief Executive Officer, Immumap

Thomas Mørch Frøsig, Chief Executive Officer, Immumap

Michela Gabaldo, Head Of Alliance Management, Fondazione Telethon

Chiara Gai, Chair, EvoBiotech

Eli Gajraj, Principal Technical Adviser, National Institute for Health and Care Excellence

Sapan Gandhi, Director, Drishti Discoveries

André Gerth, Chief Executive Officer, BioPlanta GmbH

Faruque Ghanchi, Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (Born), Specialty Lead- Ophthalmology, Bradford Teaching Hospitals N.H.S. Foundation Trust

Faruque Ghanchi | Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (Born), Specialty Lead- Ophthalmology | Bradford Teaching Hospitals N.H.S. Foundation Trust » speaking at Advanced Therapies

Paul Gissen, UCL Great Ormond Street Institute of Child Health

Janet Glassford, senior quality assessor, Medicines & Healthcare Products Regulatory Agency

Janet Glassford | senior quality assessor | Medicines & Healthcare Products Regulatory Agency » speaking at Advanced Therapies

Simon Goldman, Investment Director, Albion Capital

Simon Goldman | Investment Director | Albion Capital » speaking at Advanced Therapies

Matthias Gossmann, Managing Director, InnoVitro

Cecilia Gotherstrom, Research Leader And Associate Professor, Karolinska Institutet

Julian Gough, Chief Scientific Officer, Mogrify

Lise Marie Grav, Postdoc, Technical University of Denmark

Amy Gray, Chief Executive Officer, Charcot-Marie-Tooth Association

Boris Greber, Chief Scientific Officer, RheinCell Therapeutics

David Greenwald, Vice President Of Business Development, Deerfield Management

Uta Griesenbach, Professor, Molecular Medicine, National Heart And Lung Institute; President, British Society For Gene And Cell Therapy;, Imperiai College London

Ravindra Gupta, Wellcome Trust Senior Fellow In Clinical Science, Ucl Division Of Infection And Immunity, UCL

Ravindra Gupta | Wellcome Trust Senior Fellow In Clinical Science, Ucl Division Of Infection And Immunity | UCL » speaking at Advanced Therapies

Miriam Haak, Business Development Manager, Miltenyi Biotec GmbH

Miriam Haak | Business Development Manager | Miltenyi Biotec GmbH » speaking at Advanced Therapies

Sam Hall, Partner, Apple Tree Partners

Sam Hall | Partner | Apple Tree Partners » speaking at Advanced Therapies

Brad Hamilton, Co-Founder And Chief Scientific Officer, GoodCell

Peter Hamley, Chief Scientific Officer, Samsara Therapeutics

Peter Hamley | Chief Scientific Officer | Samsara Therapeutics » speaking at Advanced Therapies

Patrick J Hanley, Director, Cellular Therapy Laboratory, Children's National Medical Center

Patrick J Hanley | Director, Cellular Therapy Laboratory | Children's National Medical Center » speaking at Advanced Therapies

Stephen Hart, Professor Of Molecular Genetics, Institute of Child Health - U.C.L.

Hansjorg Hauser, Head Of Department Of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Frank Hecht, Vice President Marketing And Sales, CellGenix GmbH

Christopher R Heery, Chief Medical Officer, Precision BioSciences

Gillian Hendy, Head Of Business Development, Avectas

Gillian Hendy | Head Of Business Development | Avectas » speaking at Advanced Therapies

Dawn Henke, Senior Technical Program Manager, Standards Coordinating Body

Dawn Henke | Senior Technical Program Manager | Standards Coordinating Body » speaking at Advanced Therapies

Asael Herman, CTO, Emendo Biotherapeutics

Christoph Herwig, Professor Of Biochemical Engineering, Vienna University of Technology

Edward Hodgkin, Partner, Syncona Partners

Johnny Huard, Director And Chief Scientific Officer, Center For Regenerative Sports Medicine, Steadman Philippon Research Institute

Annie Hubert, Senior Director, European Public Policy, Alliance for Regenerative Medicine

Annie Hubert | Senior Director, European Public Policy | Alliance for Regenerative Medicine » speaking at Advanced Therapies

Nick Hughes, CTO, Arthronica

Michael Hunt, Chief Financial Officer, ReNeuron Group Plc

Dejan Hušman, Chief Executive Officer, denovoMATRIX

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Phil Jackson, Head of International and Cluster Development, MedCity

Phil Jackson | Head of International and Cluster Development | MedCity » speaking at Advanced Therapies

Agnieszka Janeczek, Founder & Chief Executive Officer, Renovos

Robert Jones, Vice President, Global Bioservices, Cryoport Inc

Troels Jordansen, Chief Executive Officer, Glycostem Therapeutics

Margareth Jorvid, Head Of Regulatory Affairs And Qa, Immunicum

Margareth Jorvid | Head Of Regulatory Affairs And Qa | Immunicum » speaking at Advanced Therapies

Daria Julkowska, Scientific Coordinator, French National Research Agency

Daria Julkowska | Scientific Coordinator | French National Research Agency » speaking at Advanced Therapies

Steve Kanner, Chief Scientific Officer, Caribou Biosciences

Cornelia Kasper, Professor, Biopharmaceutical Production And Technology, BOKU

Jasmin Kee, Cell and Gene, Independent Consultant

Orion P Keifer, Vice President, Discovery and Translational Research, CODA Biotherapeutics

Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Paul Kemp, Co-Founder & CEO, HairClone

Sven Kili, Vice President And Head Of Gene Therapy Development, Sven Kili Consulting

Sven Kili | Vice President And Head Of Gene Therapy Development | Sven Kili Consulting » speaking at Advanced Therapies

Soekjoong Kim, R&D Managing Director, ToolGen

Masahiro Kino - Oka, Department of Biotechnology, Graduate School of Engineering,, Osaka University

Jak Knowles, Vice President Of Venture Investments, Bayer US LLC

Jak Knowles | Vice President Of Venture Investments | Bayer US LLC » speaking at Advanced Therapies

Jarema (Jarko) Kochan, Head Of Biomarkers, Diagnostics And Assay Development, Turnstone Biologics

Sebastian Kress, Post Doc, BOKU

Maximilian Krippl, Research Assistant, B.O.K.U. University of Natural Resources and Life Sciences Vienna

Jurgen Kuball, Center Of Translational Immunology (Cti), Department Of Hematology, UMC Utrecht

Dmitry Kuzmin, Managing Partner, 4Bio Capital

Mohamed Ladha, Vice President and Group Head, Commercial, Operations and Medical Affairs, Tocagen Inc

Mohamed Ladha | Vice President and Group Head, Commercial, Operations and Medical Affairs | Tocagen Inc » speaking at Advanced Therapies

Lawrence Lamb, Executive Vice President And Chief Scientific Officer, Incysus Therapeutics

Michael Lanero Fidalgo, COO, TreeFrog Therapeutics

Christine Le Bec, Head of CMC Gene Therapy, working on AAV vectors, Sensorion Sas

Christine Le Bec | Head of CMC Gene Therapy, working on AAV vectors | Sensorion Sas » speaking at Advanced Therapies

Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics Inc

Steven Lee, Senior Research Fellow, Institute Of Immunology And Immunotherapy, University of Birmingham

Bruce Levine, Professor, Perelman School of Medicine University of Pennsylvania

Nanxin (Nick) Li, Senior Director and Head, Health Economics and Outcomes Research (HEOR), uniQure

Tongri Liu, Chief Representative, Allife Medicine

Diana Lober, Product Manager, Schott AG

Anthony Lodge, CMC – Regulatory Lead, Kite Pharma, a Gilead Company

Friedemann Loos, Innovation Manager, BioRN Cluster Management Gmbh

Douglas Losordo, Chief Medical Officer, Caladrius Biosciences

Douglas Losordo | Chief Medical Officer | Caladrius Biosciences » speaking at Advanced Therapies

Tim Luker, Global Director, External Innovation, External Research And Development, Eli Lilly And Company

Tim Luker | Global Director, External Innovation, External Research And Development | Eli Lilly And Company » speaking at Advanced Therapies

Frank Luyten, Director, Katholeieke Universiteit Leuven

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Ross Macdonald | Chief Executive Officer | Cynata Therapeutics Ltd » speaking at Advanced Therapies

John Maher, Chief Scientific Officer, Leucid Bio

Michel Manach, Business Development Manager, Cell-Easy

Rachel Manley, Head Of Global Outreach, Save the Cord Foundation

Sakis Mantalaris, Professor, Biomedical Systems Engineering Laboratory, Georgia Institute of Technology

Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration

Peter Marks | Director, Center For Biologics Evaluation And Research (CBER) | U.S. Food and Drug Administration » speaking at Advanced Therapies

Thomas Marx, Head of Business Development, Rheincell Therapeutics GmbH

Giuseppe Mazza, Chief Executive And Scientific Officer, Engitix

Giuseppe Mazza | Chief Executive And Scientific Officer | Engitix » speaking at Advanced Therapies

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Todd C Mcdevitt, Senior Investigator, Gladstone Institute

Todd C Mcdevitt | Senior Investigator | Gladstone Institute » speaking at Advanced Therapies

Thomas Meany, Director, OpenCell.bio

Ms Sarah Meeks, Vice President Of Business Development, MaxCyte

Rob Meijer, Chief Executive Officer, Amphera

Leslie Meltzer, Vice President And Head Of Global Medical Affairs, Orchard Therapeutics

Aline Miller, Chief Executive Officer, Manchester BIOGEL

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller | Chief Scientific Officer | Cell Therapy Sciences » speaking at Advanced Therapies

Federico Mingozzi, Chief Scientific Officer, Spark Therapeutics

Federico Mingozzi | Chief Scientific Officer | Spark Therapeutics » speaking at Advanced Therapies

Maria Mirotsou, Senior Director, Research, Astellas Pharma

Maria Mirotsou | Senior Director, Research | Astellas Pharma » speaking at Advanced Therapies

Sara Mole, Professor, Molecular Cell Biology, University College London

Sara Mole | Professor, Molecular Cell Biology | University College London » speaking at Advanced Therapies

Carla Montesano, Assistant Professor, General Pathology & Immunology, Department of Biology; Member, UNESCO;, University of Rome Tor Vergata

Neill Moray Mackenzie, Chairman And Board Mamber, Immetacyte

Neill Moray Mackenzie | Chairman And Board Mamber | Immetacyte » speaking at Advanced Therapies

Paolo Morgese, Director, Market Access And Member Relations, Alliance for Regenerative Medicine

Dave C Morris, Vice President Of Therapeutic Discovery, Precision BioSciences

David Morrow, Project Manager, EATRIS

Alan Muir, Director And Co-Founder, Seven Hills Venture Partners

Alan Muir | Director And Co-Founder | Seven Hills Venture Partners » speaking at Advanced Therapies

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy | Principle Investigator | Remedi National University of Ireland Galway » speaking at Advanced Therapies

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Susan Nichols, President And Chief Executive Officer, Falcon Therapeutics

Susan Nichols | President And Chief Executive Officer | Falcon Therapeutics » speaking at Advanced Therapies

Jelena Ochs, Manager Business Unit Life Sciences Engineering, Fraunhofer Institute for Production Technology

Shirley O'Dea, Chief Scientific Officer, Avectas

Shirley O'Dea | Chief Scientific Officer | Avectas » speaking at Advanced Therapies

Steve Oh, Stem Cell Bioprocessing Director And Institute Professor, A-star

Daniel O'Mahony, Partner, Seroba Life Sciences

Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC

Nneka Onwudiwe | Founder And Chief Executive Officer | Pharmaceutical Economics Consultants of America (PECA) LLC » speaking at Advanced Therapies

Dominic O'Regan, Business Development Consultant & Investor, New Mosaic

Emanuele Ostuni, Head Of Europe, Cell And Gene Therapy, Novartis

Emanuele Ostuni | Head Of Europe, Cell And Gene Therapy | Novartis » speaking at Advanced Therapies

Myriam Ouberai, Founder & CEO, Spirea

Palani Palaniappan, Head Of Technical Operations And Andover Site, Sarepta Therapeutics

Sean Palecek, Professor Of Chemical And Biological Engineering, University of Wisconsin, Stem Cell and Regenerative Medicine Center

Ioannis Papantoniou, Adjunct Professor, KU Leuven

Maria Papathanasiou, Research Associate, Imperiai College London

Maria Papathanasiou | Research Associate | Imperiai College London » speaking at Advanced Therapies

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Vivienne Parry, Head Of Engagement, Genomics England

Vivienne Parry | Head Of Engagement | Genomics England » speaking at Advanced Therapies

Leonard Pattenden, Head Of Biotherapeutics Development And Drug Supply Biotherapeutics Development Unit, Cancer Research UK

David Pauza, Chief Science Officer, American Gene Technologies International Inc.

David Pearce, President Of Innovation And Research, Sanford Research

Adam Perriman, Professor of Bioengineering, University of Bristol

Elzbieta Maria Piatkowska, Chief Executive Officer, Remissio UG

Elzbieta Maria Piatkowska | Chief Executive Officer | Remissio UG » speaking at Advanced Therapies

Elena Piletska, Lecturer In Bioanalytical Chemistry, University of Leicester

Elena Piletska | Lecturer In Bioanalytical Chemistry | University of Leicester » speaking at Advanced Therapies

Steven Pincus, Head Of Science And Innovation, Fujifilm Diosynth Biotechnology

Stefano Pirro, Co-founder and Bioinformatics Director, MirNat

Avery Posey, Assistant Professor, University of Pennsylvania

Tanya Potashnik, Director Policy And Economic Analysis, Patented Medicine Prices Review Board, Government of Canada

Tanya Potashnik | Director Policy And Economic Analysis, Patented Medicine Prices Review Board | Government of Canada » speaking at Advanced Therapies

Martin Pule, Senior Vice President, Founder, Chief Scientific Officer, Autolus and Clinical Senior Lecturer, University College London

Dr Qasim Rafiq, Associate Professor, Bioprocessing Of Cell And Gene Therapies, University College London

Abdulkader Rahmo, Chief Executive Officer, SMSbiotech

Lior Raviv, Vice President Of Development, Pluristem Therapeutics

Antonio Regalado, Senior Editor, M.I.T. Technology Review

Antonio Regalado | Senior Editor | M.I.T. Technology Review » speaking at Advanced Therapies

Ajan Reginald, Chief Executive Officer, Celixir

Petra Reinke, Founding Director, Becat, Steering Committee Bcrt, Charite

Albert Ribickas, Bmt/Qc Laboratories Manager, Cell Therapies Facility, Moffitt Cancer Center

Jim Richardson, Senior Science And Standards Liaison, U.S. Pharmacopeia

Jim Richardson | Senior Science And Standards Liaison | U.S. Pharmacopeia » speaking at Advanced Therapies

Erik Richardson, Senior Manager, Gene Therapy R&D, Apellis Pharmaceuticals

Erik Richardson | Senior Manager, Gene Therapy R&D | Apellis Pharmaceuticals » speaking at Advanced Therapies

Antonio Rodriguez, Deputy Qualified Person. Cellular Manufacturing Unit, Regional University Hospital -Biomedical Research Institute (IBIMA) Málaga

Antonio Rodriguez | Deputy Qualified Person. Cellular Manufacturing Unit | Regional University Hospital -Biomedical Research Institute (IBIMA) Málaga » speaking at Advanced Therapies

Dr Barry Rosen, Senior Principal Scientist And Director, AstraZeneca

Nicolas Rousseau, Chief Operating Officer, EVerZom

Igor Rudychev, Head of Analytics, Novartis

Igor Rudychev | Head of Analytics | Novartis » speaking at Advanced Therapies

Christoph Ruedig, Partner, AlbionVC

Pervinder Sagoo, Director, Gene And Cell Therapy, Orchard Therapeutics

Mark Sawicki, Chief Commercial Officer, Cryoport Inc

David Schaffer, Professor, Chemical And Biomolecular Engineering, University Of California, Berkeley And Co-Founder, 4D Molecular Therapeutics

Dominic Schmidt, Partner, Syncona Investment Management Ltd

Stephanie Schorge, Professor Of Translational Neuroscience And The Wellcome Chair Of Pharmacology, University College London

Jan Schrooten, Board Member, Flanders.Bio And Chief Executive Officer, Antleron

Raghuram Selvaraju, Managing Director, h.c. wainwright

Raghuram Selvaraju | Managing Director | h.c. wainwright » speaking at Advanced Therapies

Margarida Serra, Head Of Stem Cell Bioengineering Laboratory, iBET: Instituto de Biologia Experimental e Tecnológica

Ra Session II, Chief Business Officer, BridgeBio-Gene Therapy

Ra Session II | Chief Business Officer | BridgeBio-Gene Therapy » speaking at Advanced Therapies

Maryam Shariatzadeh, Post-Doctoral Researcher, Centre For Biological Engineering, Loughborough University

Gerard Short, svp medical science, Freeline Therapeutics

Gerard Short | svp medical science | Freeline Therapeutics » speaking at Advanced Therapies

Ricardo Silva, Senior Scientist, Instituto de Biologia Experimental e Tecnologica

John Sinden, Chief Executive Officer, Glialign Limited

Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England

Yochi Slonim, Co-Founder And Chief Executive Officer, Anima Biotech

Devyn Smith, Chief Operating Officer And Head Of Strategy, Sigilon

Owen Smith, Investment Director, 4Bio Capital

Owen Smith | Investment Director | 4Bio Capital » speaking at Advanced Therapies

Luce Sohier, Business Development Sterile Solutions, Schott AG

Mangala Srinivas, Head Of Multiscale Imaging Lab, Radboud University

Mangala Srinivas | Head Of Multiscale Imaging Lab | Radboud University » speaking at Advanced Therapies

Joseph Stavas, Senior Vice President of Clinical Development, inRegen

Joseph Stavas | Senior Vice President of Clinical Development | inRegen » speaking at Advanced Therapies

Mathias Svahn, Chief Executive Officer, Nextcell Pharma

Mathias Svahn | Chief Executive Officer | Nextcell Pharma » speaking at Advanced Therapies

Magali Taiel, CMO, GenSight Biologics

Marina Tarunina, Research Director, Plasticell

Bill Tente, Chief Regulatory Officer, Humacyte

Bill Tente | Chief Regulatory Officer | Humacyte » speaking at Advanced Therapies

Stefanos Theoharis, Previously Senior Vice President Of Corporate Development And Partnering, Cell Medica, Independent Consultant

Stefanos Theoharis | Previously Senior Vice President Of Corporate Development And Partnering, Cell Medica | Independent Consultant » speaking at Advanced Therapies

Hartmut Tintrup, Head of Business Development, Europe, Lonza

Pascal Touchon, President, Chief Executive Officer And Board Member, Atara Biotherapeutics

Pamela Tranter, Translational Reserach Manager, University College London

Ted Tuddenham, Emeritus Professor Of Haemophilia, University College London

Ted Tuddenham | Emeritus Professor Of Haemophilia | University College London » speaking at Advanced Therapies

Marc Turner, Medical Director, Scottish National Blood Transfusion Service

Sheela Upadhyaya, Associate Director Hst, National Institute for Health and Care Excellence

Sheela Upadhyaya | Associate Director Hst | National Institute for Health and Care Excellence » speaking at Advanced Therapies

Evelina Vågesjo, Chief Executive Officer, Ilya Pharma

Edward Van Wezel, partner, Bgv Biogeneration Ventures

Tarun Vemulkar, Co-Founder & CTO, Semarion

David Venables, President, AskBio Europe, AskBio

Jeroen Verheyen, Co-Founder And CEO, Semarion

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Simon Waddington, Professor of Gene Therapy, UCL

John Wagner, Executive Medical Director Of B.M.T. Program, University of Minnesota

John Wagner | Executive Medical Director Of B.M.T. Program | University of Minnesota » speaking at Advanced Therapies

Sebastien Walpen, Chief Executive Officer, Ceidos

Sebastien Walpen | Chief Executive Officer | Ceidos » speaking at Advanced Therapies

Darren Walsh, Senior Director - Market Access And Government Affairs - Eu, Orchard Therapeutics

Dr Michael West, Founder And Chief Executive Officer, AgeX Therapeutics

David Wilson, Vice President EMEA, Cryoport Inc

David Wilson | Vice President EMEA | Cryoport Inc » speaking at Advanced Therapies

Annalisa Zucotti, Comm And Events Lead, BioRN

Annalisa Zucotti | Comm And Events Lead | BioRN » speaking at Advanced Therapies

 

 

 

“Let me congratulate you on a job well done in helping organise the speakers and presentations for last week's Advanced Therapies Congress. I thought the entire meeting had a lot of substance, which made it stand out from many other meetings.”

 

Editor, Evernow Publishing Ltd